Search clinical trials for: Everolimus Cyclosporine

Total 1865 results

National Heart, Lung, and Blood Institute (NHLBI)

Completed

Combination Therapy of Severe Aplastic Anemia

Severe Aplastic Anemia

United States
Pari Pharma GmbH

Terminated

L-CsA in the Prevention of Bronchiolitis Obliterans Syndrome (BOS) in Lung Transplant (LT) Patients

Bronchiolitis Obliterans

Germany
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Terminated

Lenalidomide After Donor Stem Cell Transplant and Bortezomib in Treating Patients With High Risk Multiple Myeloma

Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple Myeloma

United States
Huons Co., Ltd.

Completed

Efficacy and Safety of HE10 for Dry Eye Syndrome

Dry Eye Syndrome
Hospices Civils de Lyon

Completed

Ciclosporin A Preconditioning for Renal Artery Stenosis (CicloSAAR)

Renal Artery Stenosis

France
Medical University of Vienna

Completed

The Vienna Prograf and Endothelial Progenitor Cell Study

End Stage Renal Disease

Austria
Shanghai General Hospital, Shanghai Jiao Tong University...
Ruijin Hospital; Xinhua Hospital, Shanghai Jiao Tong University School of Medicine and other collaborators

Completed

The Efficacy of Immunosuppressive Therapy Combined With Cord Blood Transfusion in Treatment of Severe Aplastic Anemia

Severe Aplastic Anemia

China
Zambon SpA

Terminated

A Safety Study of Liposomal Cyclosporine A to Treat Bronchiolitis After Hematopoietic Transplant (BOSTON-4) (BOSTON-4)

Stem Cell Transplant Complications | GVHD, Chronic | Bronchiolitis Obliterans Syndrome (BOS)

Spain, France, Germany
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Extension Study (Extended Access) of Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans

Bronchiolitis Obliterans | Graft Versus Host Disease | Graft-Versus-Host Disease | Constructive Bronchiolitis | Bronchiolitis, Exudative | Bronchiolitis, Proliferative

United States
Allergan

Completed

Evaluation of Maintaining Visual Performance in Participants Who Engage in Electronic Visual Tasking While Using Restasis® (EMPOWER)

Dry Eye Syndromes

United States
Russian Academy of Medical Sciences
Russian Scientific Center of Surgery

Completed

Study Cyclosporine (CsA) Versus Tacrolimus (Tacro) After Campath Induction in Kidney Transplantation (RSCS-Campath)

Acute Graft Rejection | Chronic Allograft Nephropathy | Polyomavirus-related Transplant Nephropathy

Russian Federation
Mario Negri Institute for Pharmacological Research
Heart Care Foundation

Completed

CYCLosporinE A in Reperfused Acute Myocardial Infarction (CYCLE)

Acute Myocardial Infarction

Italy
Hospital Clinic of Barcelona

Terminated

Pilot Study of Immunosuppression Drug Weaning in Liver Recipients Exhibiting Biomarkers of High Likelihood of Tolerance

Liver Transplantation

Spain
Medical University of Vienna

Terminated

Improving Secretion of Insulin in New Onset Diabetes After Renal Transplantation (ISINODAT)

New Onset Diabetes Mellitus After Renal Transplantation

Austria
Vertex Pharmaceuticals Incorporated
Tibotec Pharmaceutical Limited

Completed

A Study to Examine the Effects of Telaprevir on the Pharmacokinetics of Cyclosporine and Tacrolimus in Healthy Adults

Hepatitis C

United States
Edward Hall,PhD

Withdrawn

Traumatic Brain Injury and Effects of Acute Cyclosporine A

Traumatic Brain Injury

United States
Astellas Pharma Inc
Basilea Pharmaceutica International Ltd

Completed

Drug Interaction Study of Isavuconazole and Cyclosporine

Healthy

United States
Siriraj Hospital

Completed

Efficacy Study of FK-506 and Cyclosporine in Vernal Keratoconjunctivits (VKC)

Keratoconjunctivitis, Vernal

Thailand
Novartis Pharmaceuticals

Completed

Pharmacodynamics, Efficacy and Safety of Basiliximab 40 or 80 mg in Combination With Ciclosporine Microemulsion or Everolimus, in Adult Low Risk de Novo Renal Transplant Recipients (IDEALE Study) (IDEALE)

Renal Transplantation

France
Sun Pharmaceutical Industries Limited

Completed

Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca (Emerald)

Keratoconjunctivitis Sicca

United States
University of Aarhus

Completed

Photophoresis Versus Ciclosporine in Severe Atopic Dermatitis

Atopic Dermatitis
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome

Myelodysplastic Syndromes | Leukemia

United States
Shandong University
National Natural Science Foundation of China

Unknown

Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Myelodysplastic Syndromes

Myelodysplastic Syndromes

China
Shaymaa Mohammed El-Awady

Recruiting

Evaluation of the Clinical Outcome of Cyclosporine Short Infusion Versus Continuous Infusion Post Allogenic Stem Cell Transplantation

Allogenic Bone Marrow Transplantation

Egypt
Region Skane
NeuroVive Pharmaceutical AB

Completed

Ciclosporin to Protect Renal Function In Cardiac Surgery (CiPRICS)

Acute Kidney Injury

Sweden
National Cancer Institute (NCI)

Terminated

Effect of Cyclosporine Therapy on Gene Expression in Patients With Large Granular Lymphocyte Leukemia

Large Granular Lymphocytic Leukemia | LGL Leukemia

United States
Sigmoid Pharma

Completed

PK, Safety & Tolerability of CyCol® Versus Sandimmune® in Healthy Subjects (CYC102)

Healthy
Institute of Hematology & Blood Diseases Hospital

Recruiting

Efficacy and Safety of Avatrombopag Combined With IST for the Treatment of HAAA and SAA With Abnormal Liver Function

Aplastic Anemia

China
Meir Medical Center

Unknown

Corneal Tear Film Imaging of the Cornea Before and After Restasis Therapy

Dry Eye Syndrome | Tear Film Insufficiency
University of Michigan
Bausch & Lomb Incorporated

Completed

Treatment of Ocular Graft-versus-Host Disease (GVHD) With Topical Loteprednol Etabonate 0.5% (Lotemax_BMT)

Dry Eyes
Federico II University

Unknown

Alemtuzumab and Low-Dose Cyclosporine in Treating Patients With Severe Aplastic Anemia or Acquired Marrow Failure

Nonmalignant Neoplasm

Italy
Universidade Federal do Rio de Janeiro

Unknown

Topical Cyclosporine for the Treatment of Dry Eye in Patients Infected With the Human Immunodeficiency Virus

Dry Eye Syndromes | HIV Seropositivity

Brazil
Erasmus Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Recruiting

NMF-CsA-Dupi Trial

Dermatitis, Atopic

Netherlands
Sun Pharmaceutical Industries Limited

Completed

Effect of Cequa™ in Subjects With Dry Eye Disease

Dry Eye Disease

United States
Boston Sight
Allergan

Completed

Novel Use of Cyclosporine Ophthalmic Emulsion 0.05% on Application of PROSE Devices for Management of Patients With Ocular Surface Disease

Ocular Surface Disease

United States
Allergan

Terminated

Phase 2 Study of a New Ophthalmic Formulation of Cyclosporine (Restasis® X) in Patients With Dry Eye Disease

Dry Eye Syndromes

United States
Allergan

Completed

Safety and Efficacy of Cyclosporine Ophthalmic Emulsion in Patients With Primary Pterygium

Pterygium

Singapore, United States, Australia
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Gemtuzumab Ozogamicin and Cyclosporine in Treating Older Patients With Relapsed Acute Myeloid Leukemia

Leukemia

United States
University of Medicine and Dentistry of New Jersey
Biogen

Completed

Transitioning From Cyclosporine to Alefacept in Psoriasis

Psoriasis

United States
Assistance Publique - Hôpitaux de Paris
Agence de La Biomédecine

Completed

Cyclosporine Dose Adjustment According to Calcineurin Activity After Allogeneic Hematopoietic Stem-cell Transplantation (CALCICLO)

Hematopoietic Stem Cell Transplantation | Graft Versus Host Disease

France
Rockefeller University
Facet Biotech

Completed

To Study the Effects of CD25 and Low Dose Cyclosporin in the Treatment of Active Psoriasis Vulgaris

Psoriasis

United States
University of Minnesota
Novartis; Juvenile Diabetes Research Foundation; National Institutes of Health...

Completed

Anti-Thymocyte Globulin, Cyclosporine, and RAD in Islet Transplantation (NITA)

Hypoglycemia | Type 1 Diabetes Mellitus

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); National Heart, Lung, and Blood Institute...

Completed

Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Severe Combined Immunodeficiency Undergoing Donor Bone Marrow Transplant

Severe Combined Immunodeficiency | Adenosine Deaminase Deficiency | Immune System Disorder | Autosomal Recessive Disorder | Purine-Nucleoside Phosphorylase Deficiency | Severe Combined Immunodeficiency With Absence of T and B Cells | X-Linked Severe Combined Immunodeficiency

United States
Nohla Therapeutics, Inc.
National Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaborators

Completed

Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic Malignancies

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) | Adult Acute Myeloid Leukemia... and other conditions

United States
Novartis Pharmaceuticals

Completed

SCHEDULE - Scandinavian Heart Transplant Everolimus de Novo Study With Early Calcineurin Inhibitor (CNI) Avoidance (SCHEDULE)

Renal Function and Chronic Allograft Vasculopathy

Norway, Denmark, Sweden
University of Maryland, Baltimore

Completed

Aerosol Liposomal Cyclosporine for Chronic Rejection in Lung Transplant Recipients

Bronchiolitis Obliterans | Chronic Rejection of Lung Transplant | Disorder Related to Lung Transplantation | Decreased Immunologic Activity

United States
Taejoon Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety Study of TJCS for Treatment of Moderate to Severe Dry Eye Syndromes

Dry Eye Syndromes

Korea, Republic of
East Carolina University
Astellas Pharma US, Inc.

Completed

Optima: Optimizing Prograf Therapy in Maintenance Allografts II (OPTIMAII)

Kidney Transplantation

United States
Everett Meyer

Completed

Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders

Leukemia, Myeloid | Myeloproliferative Disorders | Anemia | Neural Tube Defects | Myelodysplastic Syndromes (MDS) | Bone Marrow Transplant Failure

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); National Heart, Lung, and Blood Institute...

Completed

Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed by Unrelated Donor Stem Cell Transplant in Treating Patients With Fanconi Anemia

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) | Fanconi Anemia | Adult Acute... and other conditions

United States

Search clinical trials for: Everolimus Cyclosporine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Costa Rica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations